Win, Lose & Draw: Third Merck Vioxx Trial Ends In Mistrial
This article was originally published in The Pink Sheet Daily
Executive Summary
A Houston jury was unable to reach a verdict in the first federal product liability trial over the COX-2 inhibitor.
You may also be interested in...
Merck Wins Retrial In First Vioxx Federal Case
A New Orleans federal jury found in favor of Merck Feb. 17 in a retrial of the firm's first federal Vioxx case
Merck Wins Retrial In First Vioxx Federal Case
A New Orleans federal jury found in favor of Merck Feb. 17 in a retrial of the firm's first federal Vioxx case
Second Date For Merck: Retrial Set For Feb. 6
A retrial of the first federal Vioxx product liability case is scheduled to begin on Feb. 6, the firm announced